Oncobox YC-Bewerbung

Summer 2017Active

Oncobox durchlief Y Combinator im Summer 2017-Batch als ein Healthcare-Unternehmen. Unten: Was das Unternehmen tut, wer es gegründet hat und seine Bewerbung bei YC, Frage für Frage im echten YC-Formular rekonstruiert.

YC-Batch: Summer 2017
Branche: HealthcareDiagnostics
Teamgröße: 11
Status: Active
Gestartet: 2017

Gründer

Andrew GarazhaFounder/CEO
Anton BuzdinFounder/CSO

Was Oncobox tut

Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. How does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs. Oncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient. We actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at. Our team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.

Oncoboxs YC-Bewerbung, rekonstruiert

Y Combinator Bewerbung

Oncobox, Summer 2017 Batch. Die echten Fragen des Antrags, beantwortet aus öffentlichen Daten.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Oncobox

Describe what your company does in 50 characters or less.

Finding the right cancer drug for each patient.

What is your company going to make? Please describe your product and what it does or will do.

Oncobox analyzes tumor DNA, RNA, and molecular pathways to produce a report that helps oncologists pick the most effective targeted cancer drugs for an individual patient. Our product focuses on late-stage cancer patients, where current targeted therapies only work 25% of the time. Our system increases that effectiveness significantly by identifying the key molecular targets specific to each tumor.

Where do you live now, and where would the company be based after YC?

We live in Walnut, CA and would base the company here after YC.

Explain your decision regarding location.

We are already based in Walnut, CA and want to stay here because of access to regional research partners and proximity to biotech clusters in California.

21 weitere Antworten in der vollständigen Bewerbung

Founders, Progress, Idea, Equity, Curious, Batch Preference sind in der Vollversion. Erstelle ein kostenloses Konto, um es in YC Insights neben jedem anderen YC-Batch zu öffnen.

Vollständige Bewerbung anzeigen

Häufig gestellte Fragen

Ist das die echte YC-Bewerbung von Oncobox?

Nein. Y Combinator hält eingereichte Bewerbungen privat. Dies ist eine Rekonstruktion: die echten Fragen des YC-Formulars, beantwortet aus den öffentlichen Daten von Oncobox (Veröffentlichungsnotizen, Gründerhintergründe, Produktbeschreibung). Sie zeigt, wie sich ein Unternehmen wie Oncobox bei YC präsentieren würde, nicht den Text, den sie eingereicht haben.

In welchem YC-Batch war Oncobox?

Oncobox war Teil des Y Combinator Summer 2017-Batches.

Wer hat Oncobox gegründet?

Oncobox wurde von Andrew Garazha, Anton Buzdin gegründet.

Was macht Oncobox?

Finding the right cancer drug for each patient.

Wie lese ich die vollständige, rekonstruierte Bewerbung?

Erstelle ein kostenloses Round Funded Konto. Die vollständige 26-Antwort-Version der Bewerbung von Oncobox, und jede andere YC-Kohorte, findest du in YC Insights.